Cargando…
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
BACKGROUND AND PURPOSE: Local re-treatment of radiorecurrent prostate cancer is potentially curative. However, the increased risk of severe toxicity may outweigh the opportunity of cancer control. This study aims to evaluate treatment-related toxicity from ultrafocal salvage high-dose-rate brachythe...
Autores principales: | van Son, Marieke, Peters, Max, Moerland, Marinus, van de Pol, Sandrine, Eppinga, Wietse, Lagendijk, Jan, van der Voort van Zyp, Jochem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750686/ https://www.ncbi.nlm.nih.gov/pubmed/33364450 http://dx.doi.org/10.1016/j.ctro.2020.12.002 |
Ejemplares similares
-
Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020) -
Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018) -
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021) -
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017) -
Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)